Independent committee says Praxis’ tremor drug trial unlikely to meet main goal

(Reuters) – Praxis Precision Medicines said on Friday an independent committee had recommended its tremor drug trial be stopped for futility, as it was unlikely to meet its main goal.

(Reporting by Sriparna Roy in Bengaluru; Editing by Shreya Biswas)